Total Payments
$333,030
2024 Payments
$46,601
Companies
29
Transactions
929
Medicare Patients
3,090
Medicare Billing
$414,335
Payment Breakdown by Category
Other$280,710 (84.3%)
Food & Beverage$31,060 (9.3%)
Travel$14,103 (4.2%)
Consulting$6,707 (2.0%)
Education$451.02 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $280,710 | 139 | 84.3% |
| Food and Beverage | $31,060 | 739 | 9.3% |
| Travel and Lodging | $14,103 | 38 | 4.2% |
| Consulting Fee | $6,707 | 3 | 2.0% |
| Education | $451.02 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $108,498 | 185 | $0 (2021) |
| ABBVIE INC. | $70,124 | 96 | $0 (2024) |
| ITI, Inc. | $65,553 | 82 | $0 (2023) |
| Allergan, Inc. | $29,858 | 79 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26,335 | 37 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $16,291 | 49 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $4,344 | 95 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,217 | 55 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $1,419 | 29 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,404 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,601 | 123 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($26,335) |
| 2023 | $82,311 | 178 | ABBVIE INC. ($43,486) |
| 2022 | $37,795 | 134 | ITI, Inc. ($27,548) |
| 2021 | $22,841 | 107 | ITI, Inc. ($17,261) |
| 2020 | $8,847 | 70 | Sunovion Pharmaceuticals Inc. ($4,677) |
| 2019 | $18,740 | 68 | Sunovion Pharmaceuticals Inc. ($11,981) |
| 2018 | $46,665 | 116 | Sunovion Pharmaceuticals Inc. ($39,445) |
| 2017 | $69,229 | 133 | Sunovion Pharmaceuticals Inc. ($52,230) |
All Payment Transactions
929 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $30.11 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $119.20 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $41.27 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $24.55 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/27/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: Neuropsychiatry | ||||||
| 10/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $37.43 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| 09/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.34 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $119.23 | General |
| Category: Insomnia | ||||||
| 09/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Neuropsychiatry | ||||||
| 09/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $27.90 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 627 | 1,555 | $290,290 | $97,156 |
| 2022 | 11 | 755 | 1,705 | $576,525 | $100,152 |
| 2021 | 13 | 857 | 1,972 | $319,940 | $114,984 |
| 2020 | 12 | 851 | 1,905 | $320,159 | $102,043 |
Total Patients
3,090
Total Services
7,137
Medicare Billing
$414,335
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 450 | $81,000 | $31,074 | 38.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 126 | 365 | $73,000 | $24,687 | 33.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 82 | 399 | $59,850 | $15,749 | 26.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 117 | 140 | $35,000 | $8,994 | 25.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 49 | 49 | $17,100 | $6,974 | 40.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 54 | 63 | $9,500 | $3,504 | 36.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 22 | 23 | $4,600 | $2,190 | 47.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 28 | 34 | $5,440 | $2,171 | 39.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 18 | 32 | $4,800 | $1,815 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 437 | $78,660 | $29,116 | 37.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 115 | 275 | $145,736 | $19,970 | 13.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 86 | 397 | $59,550 | $12,810 | 21.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 108 | 127 | $31,700 | $10,714 | 33.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 52 | 54 | $108,092 | $7,937 | 7.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 81 | 135 | $111,083 | $6,705 | 6.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 38 | 71 | $10,650 | $3,815 | 35.8% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 35 | 36 | $7,250 | $3,347 | 46.2% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 67 | 123 | $15,214 | $2,386 | 15.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 28 | 35 | $5,590 | $1,996 | 35.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $3,000 | $1,357 | 45.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 129 | 424 | $76,320 | $24,849 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 134 | 149 | $29,800 | $16,959 | 56.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 121 | 332 | $50,215 | $16,721 | 33.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 270 | $43,170 | $16,318 | 37.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 48 | 49 | $15,925 | $7,872 | 49.4% |
About Dr. Juan Espinosa Pacc, MD
Dr. Juan Espinosa Pacc, MD is a Psychiatry healthcare provider based in Aventura, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750381026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Espinosa Pacc, MD has received a total of $333,030 in payments from pharmaceutical and medical device companies, with $46,601 received in 2024. These payments were reported across 929 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($280,710).
As a Medicare-enrolled provider, Espinosa Pacc has provided services to 3,090 Medicare beneficiaries, totaling 7,137 services with total Medicare billing of $414,335. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Aventura, FL
- Active Since 07/28/2005
- Last Updated 09/06/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750381026
Products in Payments
- LATUDA (Drug) $108,498
- VRAYLAR (Drug) $99,666
- CAPLYTA (Drug) $91,888
- SPRAVATO (Drug) $15,732
- REXULTI (Drug) $2,262
- AUSTEDO (Drug) $2,069
- BREXPIPRAZOLE (Drug) $1,562
- Austedo XR (Drug) $1,183
- NUEDEXTA (Drug) $1,045
- INGREZZA (Drug) $908.48
- HETLIOZ (Drug) $732.85
- TRINTELLIX (Drug) $703.53
- Auvelity (Drug) $578.67
- SD809-TD (Drug) $493.48
- INVEGA SUSTENNA (Drug) $474.82
- UZEDY (Drug) $428.76
- ONZETRA Xsail (Drug) $373.65
- LYBALVI (Drug) $349.04
- ARISTADA (Drug) $313.08
- ABILIFY MAINTENA (Drug) $309.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Aventura
Lori Grabois, M.d, M.D
Psychiatry — Payments: $14,154
Psychiatry $14,154
Ali-Reza Force, Md, MD
Psychiatry — Payments: $2,047
Psychiatry $2,047
Sindhura Kompella, Md, MD
Psychiatry — Payments: $1,489
Psychiatry $1,489
Dr. Jessica Kroin, Md, MD
Psychiatry — Payments: $1,136
Psychiatry $1,136
Dr. Richard Callahan, Md, MD
Psychiatry — Payments: $897.51
Psychiatry $897.51
Acelyne Summerson Garcia, Md, MD
Psychiatry — Payments: $880.47
Psychiatry $880.47